BNP Paribas Financial Markets’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $818 | Sell |
|
|||||
|
2025
Q1 | $69.3K | Sell |
|
|||||
|
2024
Q4 | $516K | Buy |
|
|||||
|
2024
Q3 | $448K | Sell |
|
|||||
|
2024
Q2 | $676K | Buy |
|
|||||
|
2024
Q1 | $362K | Buy |
|
|||||
|
2023
Q4 | $98.6K | Sell |
|
|||||
|
2023
Q3 | $157K | Buy |
|
|||||
|
2023
Q2 | $243K | Sell |
|
|||||
|
2023
Q1 | $911K | Buy |
|
|||||
|
2022
Q4 | $719K | Sell |
|
|||||
|
2022
Q3 | $1.61M | Sell |
|
|||||
|
2022
Q2 | $2.49M | Sell |
|
|||||
|
2022
Q1 | $2.6M | Buy |
|
|||||
|
2021
Q4 | $3.85M | Buy |
|
|||||
|
2021
Q3 | $677K | Buy |
|
|||||
|
2021
Q2 | $34K | Sell |
|
|||||
|
2021
Q1 | $112K | Buy |
|
|||||
|
2020
Q4 | $175K | Sell |
|
|||||
|
2020
Q3 | $237K | Buy |
|
|||||
|
2020
Q2 | $91.3K | Sell |
|
|||||
|
2020
Q1 | $64.8K | Buy |
|
|||||
|
2019
Q4 | $49.6K | Buy |
|
|||||
|
2019
Q3 | $5.07K | Buy |
|
|||||
|
2019
Q2 | $12.7K | Buy |
|
|||||
|
2019
Q1 | $14.1K | Buy |
|
|||||
|
2018
Q4 | $1.16K | Sell |
|
|||||
|
2018
Q3 | $4.73K | Hold |
|
|||||
|
2018
Q2 | $8.45K | Sell |
|
|||||
|
2018
Q1 | $34.3K | Buy |
|
|||||
|
2017
Q4 | $17.5K | Buy |
|